Animal healthcare market landscape to be underlined by technology penetration & collaborations, Global revenue to surpass USD 36 billion by 2024

Posted on

Pfizer’s spun out Zoetis, the most renowned name in animal healthcare industry, has set another milestone in the animal health fraternity by its acquisition of Nexvet, an Irish biological therapeutics company. The pact has further strengthened Zoetis’ position in animal healthcare market by building a strong solution pipeline for the company to sustain its leadership in chronic pain management for companion animals. This trend itself bears a testimony to the fact that the escalating pet ownership rate is indeed creating a remarkable impact on animal healthcare industry trends.

Europe Animal Healthcare Market, 2013-2024 (USD Million)
Europe Animal Healthcare Market, 2013-2024 (USD Million)

Increasing companion animals adoption rate ~ Animal healthcare market growth

As per the estimates, more than 65% of the U.S. households have pets, a number that is projected to increase exponentially over the coming years. U.S., on this ground, reveled the largest share in the animal healthcare industry in 2016. The region is further claimed to exhibit commendable growth prospects in the coming timeframe, driven by technology breakthroughs in pharmaceuticals and veterinary medicines sectors. China will further establish strong foothold in animal healthcare industry, driven by favorable government norms supporting pet keeping coupled with advancements in veterinary drugs. As per the estimates, China is estimated to register a CAGR of 10% over the period of 2017-2024.

Get a Sample Copy of this Reporthttps://www.gminsights.com/request-sample/detail/735

Changing animal husbandry trends to dynamically influence animal healthcare market demand

The technological innovations have led to a paradigm shift in the animal husbandry pattern. The animal health companies have also embraced this change which is vividly reflected in their business approach which has traversed a long way from therapeutics, to productivity enhancement, and ultimately to the overall animal healthcare.

India, on account of intensive animal husbandry practices, is slated to witness phenomenal gains in animal healthcare market. As per the estimates, the country accounts for 10% of the overall livestock population and holds the title of the largest producer of fish, chicken, and cattle. The region on account of its rich livestock base is rapidly turning into a profound investment destination for the animal healthcare industry players.

Increasing global population to chart a lucrative roadmap for animal healthcare market

With the rising population, the global meat and dairy consumption rate is set to increase parallelly. It is estimated that in order to feed the world in 2030, the overall animal protein production has to be increased by approximately 30% from what it is at the present. This scenario vividly demonstrates the importance of veterinary drugs and medicines in animal disease prevention and animal health management approach.

Europe, driven by France and U.K., is anticipated to witness a high demand for animal derived pharmaceutical proteins over the coming years, which will indeed make this region a strong ground witnessing animal healthcare market expansion. As per the estimates, the region held 25% of the overall market share in 2016.

M&As, collaborations, geographic expansion, and R&D to underline animal healthcare industry strategic landscape

Over the years, this industry has strongly been characterized by product innovations, geographical expansion, R&D, and collaborations. Pertaining to this, some of the prominent moves with regards to this fraternity are as listed under:

  • In 2015, Eli Lilly and Company acquired Novartis Animal Health for a deal valuation of USD 5.4 billion which reinforced the former’s health division, Elanco’s position in the global animal healthcare market space by enhancing its global commercial presence and R&D capabilities.
  • In Jan 2017, the animal healthcare industry registered one of the biggest deals with the collaboration between Sanofi and Boehringer Ingelheim (BI). The deal which was initialized in 2015 was finally closed in Jan this year when Sanofi’s animal health business, Merial was acquired by BI while Sanofi took over the latter’s consumer healthcare business. The deal made Boehringer Ingelheim the world’s second largest animal health company.
  • In Jan 2017, Elanco acquired BI Vetmedica, Inc’s U.S. portfolio of feline, rabies, and canine vaccines under a deal value of USD 885 million.
  • In July 2017, Zoetis acquired Nexvet, a Tullamore based animal therapeutic company, to develop a pipeline for monoclonal antibody therapies for companion animals.
  • Recently, MSD Animal Health, also known as Merck Animal Health, declared its plan to purchase a new manufacturing facility in Austria so as to expand its global vaccine manufacturing capacity.
  • Lately, Creso Pharma in collaboration with Virbac, a renowned pharmaceutical animal health company announced to launch hemp-based animal feed products in Switzerland.

Technological innovations to draw the future landscape of animal healthcare market

Traditional strategies might no longer serve the purpose for animal healthcare industry participants over the coming technology-driven years. With the regulatory barriers subsiding gradually, the competition is getting rather intense. In this scenario, it is a must for the animal health companies to revise their business models and approach in sync with the evolving environment. Digital technologies, in this regard, can be a potential platform to enhance the service and product portfolios of the companies. For instance, since 2016, Merial has collaborated with Georgia Institute of Technology’s Center for the Development and Application of Internet of Things Technologies to explore ways in which IoT can help in advancing animal healthcare.

Zoetis is also seeking the help of digital technologies to deliver values to its customers. The firm is participating in a U.K. based project to develop visual imaging means to aid the farmers with enhancing their production efficiency.

With these innovations, it is rather undeniable that the animal healthcare industry is all set to witness commendable gains in the ensuing years. As per the estimates, the global animal healthcare market recorded a valuation of USD 26 billion in 2016 and is slated to surpass USD 36 billion by 2024.

Author Name : Shikha Sinha

Pet cancer therapeutics market to witness a double-digit (10%) growth over the period of 2017-2024, Chemotherapy to substantially contribute to the industry revenue

Posted on

Launching of Tanovea-CA1, the FDA approved animal drug for treating canine lymphoma is indeed a breakthrough in pet cancer therapeutics market. Synonymous with lymphosarcoma, this detrimental disease is the most common type of cancer affecting dogs. Center for Veterinary Medicine, a subsidiary of U.S Food and Administration has recently announced a partial approval to this groundbreaking anti-cancer drug and depending upon the effectiveness, market experts anticipates its full approval within few years. A Colorado State University startup, VetDC Inc., is commercially merchandizing these drugs and are presently available in the U.S. market by licensed veterinarians. Reportedly, TANOVEA-CA1 is the only effective animal drug available in pet cancer therapeutics market for the treatment of lymphoma.

U.S Pet cancer therapeutics market, by medicine type, 2013 – 2024 (USD Million)

U.S Pet cancer therapeutics market, by medicine type, 2013 - 2024 (USD Million)

In veterinary oncology, chemotherapy is the most recognized therapeutic model that is extensively deployed as one of the most relatively effective methodologies of treatment. In fact, in 2016, chemotherapy held the largest share of the overall pet cancer therapeutics industry. However, as stated by a reputed pet care organization, the goal of chemotherapy treatment in veterinary patients is slightly different from that of human patients. In case of pet cancer treatment, outgrowth of cancer cells is tried to limit as much as possible but not at the cost of their quality of life. However, it has been noticed that cats and dogs respond to chemotherapy much better than humans, which again is pushing pet cancer therapeutics market from chemotherapy.

Get a Sample Copy of this Reporthttps://www.gminsights.com/request-sample/detail/2017

 

Enlisted below are some of the common drugs that are used in chemotherapy:

Drug Effective against Administration Side effects
Carboplatin Carcinoma Sarcoma (Osteosarcoma in dogs) Intravenous Bone marrow suppression

Loss of appetite and vomiting in small dogs

Doxoribicin

(Adriamycin)

Lymphoma(dogs)
Some sarcomas
Intravenous Vomiting

Heart toxicity

Kidney toxicity (cats)

Chlorambucil

(Leukeran)

Chronic lymphoid leukemia

Low grade lymphoma

Oral Seizures

Bone marrow suppression

Liver toxicity (uncommon)

Lomustine (CCNU) Lymphoma

Mast cell tumors

Histiocytic sarcoma

Some brain tumors

Oral Bone marrow suppression

Liver toxicity

Kidney toxicity (uncommon)

 

Funding impacting the pet cancer therapeutics industry dynamics

Blue Buffalo Foundation and The Petco Foundation have entered a partnership to provide a grant of USD 750000 to Morris Animal Foundation. Reportedly this grand sum of investment is an initiative taken to fund Morris Animal Foundation’s research initiative related to osteosarcoma and other additional studies related to pet cancer. Out of the total grant, USD 500000 is reported to invest in the Foundation’s Osteosarcoma Initiative. Surveys depict that osteosarcoma is a belligerent tumor that is most frequently detected in dogs. The lumpsum grant unquestionably will bring an awareness that would result in an enhancement in the pet cancer therapeutics industry outlook.

As per a recent report put forward by Global Market Insights, Inc., Pet cancer therapeutics market is forecast to exceed a revenue of USD 300 million by 2024, with a projected CAGR of 10% over 2017-2024.  Some of the prominent biggies in the pet cancer therapeutics market include Zoetis, Aratana Therapeutics Merial, AB Science, VetDC, Vetivax, Karyopharms Verdinexor, and Regeneus. The industry is rather new and is rapidly expanding with regards to product development and expansive pool of veterinary patients affected with cancers. Though the fraternity till date has been substantially dominated by leading pharmaceutical giants, pet cancer therapeutics industry is poised to carve a profitable road map in the years ahead with a plethora of new entrants specialized in pet cancer therapy.

Author Name : Satarupa De

APAC asphalt mixing plants market to witness potential growth prospects, road construction applications to spur the regional landscape

Posted on

Strong growth outlook in the civil construction industry has charted a profitable roadmap for asphalt mixing plants market over the coming years. The spurt in demand for asphalt is being significantly driven by the repair and construction segment, that builds the world’s asphalt driveways, tunnels, highways, bridges, and airport runways. The importance of good highways for the infrastructural development has strongly agitated the growth of asphalt mixing plants industry in several countries. In fact, speaking on statistical terms, more than 70% of the overall asphalt production is utilized for road developments across the globe. The developing countries with immense growth opportunities are expected to become significant hotspots for investment. Interestingly, asphalt mixing plants industry players are looking to tap the growing demand by launching innovative products with competitive technical properties. One such example is of the 2013’s collaboration of Ammann Research & Development Center with Apollo India Private Ltd, to innovate and manufacture asphalt pavers, soil compactors and asphalt mixing plants.

U.S. asphalt mixing plants market size, by process, 2013 – 2024 (USD Million)
U.S. asphalt mixing plants market size, by process, 2013 - 2024 (USD Million)

The governments of various Asian countries including China, Malaysia, Thailand, India, and Japan are financing huge amount of capital to develop road infrastructure as they act as catalyst to country’s development and economic growth. In 2016, Asia Pacific asphalt mixing plants market generated revenue over USD 2.5 billion and is foreseen to hold a major share of the market pie over the coming years. Owing to the robust growth in the countries of Asia Pacific and Latin America, asphalt mixing plants industry from road construction application generated revenue over USD 5.5 billion in 2016.

Get a Sample Copy of this Reporthttps://www.gminsights.com/request-sample/detail/1998

Considering the energy efficiency factor, one of the key trends in asphalt mixing plants industry is the refinement of recycled asphalt pavement (RAP). The market for asphalt plant equipment with RAP are gaining considerable traction in the US and Europe, with China being on wild card. The asphalt mixing plants industry players are designing new plants to produce higher quality output and also handle the higher percentages of RAP. For instance, E-MAK, a Turkish company has been developing a novel concept to optimize the throughput of asphalt plant. This company has designed a unit called Sandry which dries the sand being used in the mix and thus reduce energy usage and improve the overall efficiency of the asphalt mixing plants. Thus, the growing demand for improving the operational efficiency and develop high end technical products is set to propel the growth of asphalt mixing plants industry size over 2017-2024.

The harmful gases and volatile organic compounds emitted from the asphalt mixing plants pose a major threat to the growth of this industry. The environment threats pertaining to asphalt components and its quality and usage are being strongly monitored by the agencies such as EAPA, NAPA, and Association of Asphalt Paving Technology, which may hamper the asphalt mixing plants market expansion. However, many asphalt mixing plants industry players are adopting the sustainable green technology and environment friendly raw materials to combat the pollution problems associated with asphalt mixing plants. This is set to create huge growth opportunities for the industry players to develop sustainable and eco-friendly materials with regards to asphalt mixing and grab lucrative growth avenues over the coming years. One such instance is of Local Self-Government Department of Thiruvananthapuram, India. In a move to adopt green technology, the LSGD used an emulsion-based mix in asphalt instead of hot bitumen for the construction of road. Globally, asphalt mixing plants industry is set to witness a remarkable growth trajectory with a CAGR estimation of 1.4% and exceed revenue generation of USD 7 billion by 2024.

Author Name : Ojaswita Kutepatil

APAC pulp & paper enzymes market to experience remarkable gains over 2017-2024, shifting trends toward eco-friendly packaging to enhance industry growth

Posted on Updated on

The adoption of strategies like ‘waste to useful commodity’ to reduce waste in the environment is certain to spur pulp & paper enzymes market. An instance of this fact can be attributed to a series of events that has taken place in the U.S. in recent years. In the year 2014, it was reported that the farmers near the area of southeastern Washington had burned nearly 400,000 tons of straw residue with the permission of the State Department of Ecology, which emitted 556,000 tons of carbon dioxide. In order to reduce the hazardous effect of CO2 on the environment, the government established a pulp mill in the area. Apparently, waste wheat and alfalfa straw would be used to extract cellulose in this mill, thereby leading to twin benefits of waste straw usage for environment conservation and cellulose production from the wheat and straw processing. The implementation of this strategy on a large scale is likely to impel pulp & paper enzymes industry share. As per the estimates, in 2016, pulp & paper enzymes market generated a revenue of USD 125 million.

U.S. Amylases Pulp & Paper Enzymes Market, By Application, 2013-2024, (Tons)
U.S. Amylases Pulp & Paper Enzymes Market, By Application, 2013-2024, (Tons)

 

As per a reliable survey conducted across the U.S., 62% of the consumers have negative opinions about the brands which does not use eco-friendly packaging. Most of the brands therefore, have been striving to adopt sustainable retail packaging strategies to satisfy the consumer needs. Nashville for instance, has been creating printed paper packaging for decorative packaging such gift wrappers. The rapidly expanding retail sector across various regions of the globe is likely to boost pulp & paper enzymes industry size. Moreover, for medication packaging, most of the pharma companies are using child resistance paperboard packs, creating new growth avenues for pulp & paper industry players. Recently, a packaging company – Keystone Folding Box, launched the Ecoslide-OTC, which is made from 100% recyclable paperboard. Increasing use of paper in pharma packaging application is slated to propel pulp & paper enzymes market share.

Get a Sample Copy of this Reporthttps://www.gminsights.com/request-sample/detail/1995

Speaking about the cardboard industry, it is to be noted that the amylase enzyme is increasingly used for various purposes such as coating of starch, deinking, drainage improvement, and cleaning. As per estimates, pulp & paper enzymes market from amylase will surpass a revenue collection of USD 75 million by the end of 2024. Industry giants are continuously focusing on the development of various enzymes such as cellulose, amylase, protease, lipase, and Pectinase, which are prominently used in fiber modification and hydrolyzation, thereby helping to improve the softness of tissue. Speaking of which, Buckman Laboratories, Krishna Speciality Chemicals, AB Enzymes, MetGen, Rossari Biotech, Iogen Corporation, Anthem Cellutions pvt. Ltd., Novozymes, KPS Bio, Enzymatic Deinking Technologies, Dupont, Enzyme Solutions, Biotech, and Nature BioScience Pvt. Ltd are the prominent players in pulp & paper enzymes market.

Considering the future scope of the pulp & paper industry, it would be prudent to mention that research institutes are focusing on the enhancement of alkalinity strength and thermostability of the enzymes. Most of the U.S. based pulp & paper market firms are heavily investing in research & development activities and product innovation to dominate the business space over the coming years. North America pulp & paper enzymes market, as per estimates, will exhibit a CAGR of above 5.5% over 2017-2024, due to the presence of major industry players. The emergence of advanced manufacturing technologies will also favor the companies for large scale production. Enzymes being green chemicals, the participants in pulp & paper enzymes industry are willing to use it to improve the operations in pulp & paper manufacturing. Global Market Insights, Inc. estimates pulp & paper enzymes market to collect a notable revenue of more than USD 225 million by 2024.

Author Name : Sunil Hebbalkar

Industrial Head Protection Market to accrue a massive share via construction applications over 2017-2024, U.S. to majorly influence the regional demand

Posted on Updated on

Industrial Head Protection Market growth is highly impacted due to mergers & acquisitions, new product launches, and product differentiations. For instance, in July 2017, MSA Safety Incorporated, a manufacturer of safety equipment based in the U.S., declared the complete acquisition of Globe Holding Company, LLC, a leading U.S. based manufacturer of firefighting boots and protective clothes, for USD 215 million. With this purchase, MSA has further reinforced its leading position across PPE (Personal Protective Equipment) sector in North America. The acquisition has helped MSA to further enhance its product portfolio that find applications across the construction, oil & gas, mining, defense, fire service, and petrochemical sectors, thereby augmenting the scope of industrial head protection industry.

U.S. Industrial Head Protection Market Size, By Application, 2016 & 2024, (USD Million)
U.S. Industrial Head Protection Market Size, By Application, 2016 & 2024, (USD Million)

Today, construction companies have designed a new kind of safety helmet to offer protection to the workers who have sustained fatal head injuries. The OSHA (Occupational Safety and Health Administration) has passed legislations that mandate the use of protective helmets for the workers at locations where there is a possibility of sustaining head injuries due to electric shock impact, burns, and falling or flying objects. Global Market Insights, Inc., states that industrial head protection industry, which generated a revenue of more than USD 2.3 billion in 2016, is slated to hit a revenue of more than USD 3.4 billion by 2024.

Low costs and rise in worker efficiency along with declining incidences of worker injury will boost the demand for sensors and smart wearables across the industrial head protection market. Personal protective equipment manufacturers are devising new methods to augment the health quality and safety of workers. For instance, Scott Safety, a U.S based manufacturer of PPE and respiratory equipment, has created firefighting equipment such as PPE wearable devices as well as sensor-embedded solutions. Multinational firm Honeywell International incorporation is producing smart helmets for the factory workers to improve their safety as well as efficiency. The aforementioned factors are expected to create bright growth prospects for industrial head protection industry.

Get a Sample Copy of this Reporthttps://www.gminsights.com/request-sample/detail/1963

Even firms which are not involved in the business of producing personal protection equipment have made heavy investments in the production of smart helmets to explore the growth opportunities across industrial head protection market. For instance, a U.S. based augmented reality firm Daqri has designed wearable devices referred to as ‘smart helmets’, for industrial employees.

Many of the business players have realized the significant usage of smart sensors and connected devices across the personal protective equipment sector. For instance, in the U.S., many PPE manufacturers are using the data collected from smart sensors to enhance their operational efficiency and productivity. Smart PPE can detect danger signals which can result in a fatal accident or a head injury, which is expected to boost the industrial head protection market revenue over the years ahead.

Regional trends influencing industrial head protection market size

  • Strict legislations enforcing the use of safety helmets across the manufacturing sector are speculated to impel the business expansion across Germany, in turn contributing majorly towards Europe industrial head protection industry share over the coming timeframe.
  • U.S. safety helmet sector, which will record a CAGR of more than 3.5% over 2017-2024, will heavily influence the business space over the coming years. Strict compliance standards set by OSHA regarding worker safety will impact the product trends across the region.
  • A growing number of construction projects will favorably leverage the growth map of industrial head protection industry across China, which is contemplated to make lucrative contributions of over USD 300 million towards APAC industrial head protection industry by 2024.

Globally, industrial head protection market share is fragmented, with huge corporations and SMBs making substantial contributions toward the industry size. These participants are highlighting on key business growth aspects such as R&D activities to manufacture new products and sustain their position. Some of the major players involved in industrial head protection industry include DuPont, The 3M Company, Texas American Safety Company, and Gateway Safety Incorporation.

Author Name : Dhananjay Punekar

Brewing enzymes market to establish its space in the sustainability landscape, novel enzyme application in beer production to boost the industry growth over 2017-2024

Posted on Updated on

Charles Wells’ recent sale of the Bedford brewery to Marston’s is one of the many deals that indicates the developments in Brewing Enzymes Market. The deal, supposedly signed for a valuation of GBP 55 million, grants Marston’s, the brewer & pub operator, the complete, exclusive business and beer distribution rights, thereby augmenting the position of the manufacturer in the regional brewing enzymes industry. The extensive demand for beer and alcoholic beverages is one of the many principal drivers fueling the demand for brewing enzymes market. As per estimates, beer production surpassed around 1.9 billion hectolitres in 2016, with China alone contributing around 430 million hectolitres to this amount. The same year recorded consumer expenditure on alcoholic beverages to exceed USD 222 billion globally. These estimates provide copious evidence to the fact that brewing enzymes industry is undoubtedly here to stay, having held a valuation of more than USD 230 million in 2016.

U.S. Amylases Brewing Enzymes Market Size, By Function, 2016 & 2024 (Tons)
U.S. Amylases Brewing Enzymes Market Size, By Function, 2016 & 2024 (Tons)

Brewing Enzymes Market: An Introduction to Beer Production

The conventional beer brewing process involves soaking and heating the barley grain, which ultimately produces its own enzymes, that convert barley starch into fermentable sugars. Essentially, the barley is malted, kilned, post which wort is manufactured from the extracted malt. Furthermore, the wort is cooked, treated, fermented, filtered, and then stabilized. The malting process, basically, holds the force of attention in this entire methodology, since the process primarily aims to achieve the maximum production of enzymes such as β-glucanase and α-amylase, in addition to encompassing the maximum depolymerisation of β-glucan and starch. It is to be remembered that the mashing process basically aims to produce extensive quantities of fermentable sugars in liquor that can be easily filtered. Enzymes such as β-amylases are already present in barley, but the lion’s share of enzymes such as proteases and α-amylases are produced during the germination process.

Get a Sample Copy of this Reporthttps://www.gminsights.com/request-sample/detail/2009

Unveiling the enzyme landscape of brewing enzymes industry: Current and Future Trends

A research report by Global Market Insights, Inc., segments brewing enzymes market into xylanases, proteases, amylases, and beta-glucanases. Alpha-amylase and beta-amylase are particularly considered the most crucial enzymes contributing toward beer production, making amylases one of the most lucrative product segments of brewing enzymes industry. While both are vital indicators of the malt quality and are completely responsible for the release of fermentable sugars from starch during the mashing segment of wort production, it is to be remembered that they do have some strikingly varying characteristics. For instance, alpha-amylase is essentially an endo-acting enzyme responsible for hydrolyzing α-1,4 glucose linkages in the starch, while beta-amylase is an exo-acting enzyme that dissects maltose units from the starch.

Amylases ensure that the mashing process is consistent and uniform, without any irregularities. Furthermore, these enzymes ensure enhanced fermentation and filtration – which are the key factors contributing toward high-quality beer production. In the light of these properties, amylases-based brewing enzymes market was worth more than USD 75 million in 2016. It has been forecast that this segment will stand to gain substantial returns over the forthcoming years, possibly with reference to the fact that its usage leads to the rising production of fermentable glucose during beer production. Summating this driver with the fact that the demand for beer has been rising exponentially across numerous geographies, especially North America and Asia Pacific, will unquestionably carve a profitable growth map for brewing enzymes industry from amylases over 2017-2024.

Unlike amalyses, beta-glucanase is the vital enzyme that contributes toward the hydrolysis of beta-glucans during the malting & mashing processes. Higher levels of beta-glucans deliver high viscosity wort, which are appropriately hydrolyzed by beta-glucanases. Pertaining to the fact that this enzyme imparts excellent filtration, enhances wort separation, and lowers the viscosity levels in the wort, brewing enzymes market from beta-glucanases has been forecast to register a demand of more than 5000 kilotons by 2024, which accounts for approximately 30% of the overall brewing enzymes industry share by 2024. One of the most crucial drivers fueling the adoption of this product across breweries is that it helps enhance the beer quality with unmalted barley. This enzyme has been touted by experts to be a lucrative investment avenue for brewing enzyme market giants.

Brewing enzymes industry: Riding on the emblem of sustainability

Of late, brewing enzymes market has been experiencing a paradigm shift in accordance with the ongoing sustainability trends. It is noteworthy to mention that beer production and distribution had already entered the sustainability terrain when Harboe, the Danish brewery, had launched the use of a new enzyme for beer production in 2009, inscribing its name on the prestigious lineup of brewing enzymes market players that were some of the first ones to proliferate sustainable beer production. The new sustainable beer had apparently been christened as Clim8 Beer, which had come into being as a result of the two-year collaboration between Novozymes, the reputed brewing enzymes industry behemoth and Harboe.

The eco-friendly trend still continues to rule the charts, given that brewing enzymes market is highly controlled by changing consumer preferences and a rather stringent regulatory framework. On that note, it is prudent to mention that the beer magnate, Carlsberg, has recently launched a new sustainability program, in a bid to reduce the water usage by 50% and to eliminate carbon footprints by the year 2030. Tentatively titled ‘Together Towards Zero’, the project is categorized into four individually handled sub-projects, namely, Zero water waste, Zero accidents culture, Zero carbon footprint, and Zero irresponsible drinking. Zero carbon footprint is the goal that aims to source 100% of the electricity required at Carlsberg’s breweries by 2022 and also reduce the carbon emissions at these breweries by 30% by 2030. The brewing enzymes industry enterprise, through the Zero water waste program, aims to reduce the amount of water used by its breweries, by 50%.

Backed by a set of strict reforms, brewing enzymes market is certain to achieve an appreciable growth in the ensuing years. Judging by consumer reactions, it would seem that they are sufficiently content enjoying a glass of this beverage, basking in the valuable know-how of the fact that has indeed been sourced through a brewery that endorses sustainable solutions. Furthermore, the latest preferences of customers have been inching toward consuming beer that has been brewed with 100% unmalted barley, which will undeniably expand the scope for brewing enzymes market in the years to come.

As the experts claim, the future of brewing enzymes industry comprehends a widespread deployment of enzymes to be brewed with barley. In addition, alternative processes for beer and wort production that manifest high-grade productivity and endorse a robust reduction in the production of wastes and derivatives are expected to fabricate the future scope of brewing enzymes market, a lucrative business in the making, with an estimated target valuation of more than USD 390 million by 2024.

Author Name : Saipriya Iyer

Alpha lipoic acid market to accrue substantial revenue via dietary supplements applications over 2017-2024, APAC to majorly impact the regional growth

Posted on Updated on

The growth of alpha lipoic acid market can be mainly attributed to the product’s application as a remedial agent in a plethora of chronic ailments. As per the NCBI, ALA has proved to be effective for reducing oxidative stress, protecting against atherosclerosis, and improving endothelial dysfunction, on the grounds of which this compound may be used as a therapeutic agent for diabetes, cancer, Alzheimer’s, obesity, cardiovascular diseases, osteoporosis, high blood pressure, non-alcoholic fatty liver disorder, Down syndrome, glaucoma, and burning mouth syndrome. The use of alpha lipoic acid, a naturally occurring thiol antioxidant, in anti-oxidant medicine treatment for various diseases is expected to create lucrative growth avenues for alpha lipoic acid industry players. Global Market Insights, Inc., reports that alpha lipoic acid industry size is likely to surpass a revenue of over USD 19 million by 2024, recording a CAGR of more than 6% over 2017-2024.

U.S. alpha lipoic acid market size, by product, 2013 – 2024 (USD Thousand)
U.S. alpha lipoic acid market size, by product, 2013 - 2024 (USD Thousand)

In 1959, Germany became the first country to demonstrate the medical use of ALA for treating diabetic sensorimotor polyneuropathy due to amanita phalloides, which is a kind of mushroom abundantly found across Europe. Researchers have stated that the product, in its compact form – dihydrolipoic acid, can function as a metal chelator and biological antioxidant, helping to reduce the oxidized forms of glutathione, vitamin C, and vitamin E. Moreover, the product can also act upon signaling transduction of pathways such as adenosine monophosfatase protein kinase, insulin pathway, and nuclear factor kappa B. Alpha lipoic acid industry is expected to experience heavy capital investments from existing industry players as well as new entrants due to huge growth opportunities offered by this fraternity, subject to its widespread scope of applications.

Get a Sample Copy of this Reporthttps://www.gminsights.com/request-sample/detail/1605

The conclusions drawn from several experimental studies have proved that ALA can inhibit the growth of atherosclerosis plaque as well as atherosclerosis and can lower oxidative stress occurring post heavy training activities. Today, ALA (Alpha Lipoic Acid) finds growing usage as a food supplement across the medical and nutritional management sectors. Rising popularity of ALA usage across myriad sectors will spur alpha lipoic acid market expansion over 2017-2024.

Despite providing benefits, ALA usage has also led to the demonstration of side effects such as skin allergies and gastrointestinal distress issues such as abdominal pain, nausea, dyspepsia, and vomiting in patients who were injected with the prescribed doses of alpha lipoic acid. Results derived from the trials conducted on the patients after administering ALA have depicted the occurrence of skin ulcers, pruritus, hypoglycemia, and bronchitis in patients. As per a recent study, patients injected with ALA suffered from insulin autoimmune syndrome, which is related to the application of the product as a dietary supplement. Side-effects witnessed in the patients after the product consumption can adversely impact the development of alpha lipoic acid industry. However, research is being conducted at an international level to find out alternatives that may counter the side-effects of ALA usage.

Speaking in terms of geographical trends, alpha lipoic acid industry is set to expand its footprints across major regions – North America, Latin America, and the Asia Pacific. As per estimates, Latin America alpha lipoic acid market is slated to grow at a rate of 6% over the coming timeline. The growth graph of this business space across this region may depict an upward trend subject to the substantial government funding to improve the healthcare facilities. Brazil is forecast to be a key regional growth driver. In North America though, alpha lipoic acid market share will be considerably augmented by the emerging pharmaceutical sector and the escalating need for dietary supplements & slimming products.

The thriving medical sector across the Asia Pacific is certain to be one of key factors driving the growth of alpha lipoic acid industry across this continent. With China and India striving to enhance their healthcare infrastructure, APAC alpha lipoic acid market will carve a profitable growth curve ahead, having held a valuation of USD 3.5 million in 2016.

Despite being one of many dubious markets in the chemical sector, the competitive landscape of alpha lipoic acid industry encompasses quite a few renowned participants, namely, Sabinsa Corporation, AlzChem AG, HiMedia Laboratories, Shanghai Shyndec Pharmaceutical Company Limited, and Health Genesis Corporation. The aforementioned biggies are expected to bet big on this business in the future, according to analysts. These ALA market participants are also predicted to improve their brand presence through product portfolio expansion, joint ventures, and strategic collaborations.

Author Name : Dhananjay Punekar